First Horizon Corporation’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$273 Sell
2
-8
-80% -$983 ﹤0.01% 1487
2026
Q1
$1.18K Hold
10
﹤0.01% 1334
2025
Q4
$1.64K Buy
10
+8
+400% +$1.25K ﹤0.01% 1346
2025
Q3
$267 Buy
+2
New +$243 ﹤0.01% 1387
2021
Q2
$11K Hold
60
﹤0.01% 678
2021
Q1
$11K Sell
60
-4
-6% -$820 ﹤0.01% 664
2020
Q4
$12K Hold
64
﹤0.01% 611
2020
Q3
$9K Buy
+64
New +$9.15K ﹤0.01% 646

Other funds holding RGEN

First Horizon Corporation's RGEN Position: Q2 2026 in Review

First Horizon Corporation reduced its Repligen (RGEN) stake by 80% in Q2 2026, selling an estimated $983 and leaving 2 shares worth $273. The position accounts for ﹤0.01% of the portfolio, ranked #1487.

First Horizon Corporation first reported a position in RGEN in Q3 2020 and has held it in 8 quarters since. The position peaked at $12K in Q4 2020. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • First Horizon Corporation held 2 shares of Repligen worth $273 as of Q2 2026.
  • First Horizon Corporation sold 8 Repligen shares in Q2 2026, an estimated $983.
  • Repligen made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2026, its #1487 holding.
  • First Horizon Corporation first reported a position in Repligen in Q3 2020 and has held it in 8 quarters since.
  • First Horizon Corporation's Repligen position peaked at $12K in Q4 2020.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.